Drug interactions
Encorafenib + Pantoprazole
Severity: Minor
Encorafenib and Pantoprazole: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Pantoprazole is a BCRP substrate, and encorafenib may inhibit BCRP, which could raise pantoprazole exposure. The clinical consequence is likely small.
What this interaction means in plain words
Encorafenib and Pantoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Encorafenib belongs to Oncology; Pantoprazole belongs to Gastrointestinal Tract.
Why it happens
Encorafenib inhibits the BCRP efflux transporter, which may reduce pantoprazole efflux.
What to do
No routine adjustment is needed. Monitor for PPI adverse effects and reduce the pantoprazole dose if they appear.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Pantoprazole, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Pantoprazole
- Pantoprazole + Rilpivirine Contraindicated
- Acalabrutinib + Pantoprazole Major
- Atazanavir + Pantoprazole Major
- Dacomitinib + Pantoprazole Major
- Dasatinib + Pantoprazole Major
- Erlotinib + Pantoprazole Major
Other interactions of Encorafenib
Frequently asked questions
Can I take Encorafenib with Pantoprazole?
MediHelp rates the interaction as minor. Encorafenib and Pantoprazole have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pantoprazole is a BCRP substrate, and encorafenib may inhibit BCRP, which could raise pantoprazole exposure. The clinical consequence is likely small.
How serious is the interaction between Encorafenib and Pantoprazole?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed. Monitor for PPI adverse effects and reduce the pantoprazole dose if they appear.
What other medicines interact with Pantoprazole?
MediHelp also lists interactions of Pantoprazole with, for example, Rilpivirine, Acalabrutinib, Atazanavir. The full list is on the Pantoprazole page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
